This federal contract award, with ID SPE2DB24D2003|SPE2DB25FXGC2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,001.84, is for the delivery of VYVANSE 70 MG CAPSULE 100S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, with ID SPE2DB22D1106|SPE2DB24FFET8, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,108.48 firm fixed-price delivery order is for the supply of 100 units of VYVANSE 70 MG CAPSULE, a prescription medication. The contract has an ultimate completion date of July 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,745.96, is for the delivery of VYVANSE 60 MG CAPSULE 100S, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award, with ID SPE2DB22D3004|SPE2DB24FNT83, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,464.72, is for the delivery of 4563152875 VYVANSE 30 MG CAPSULE 100S. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $1,063.41, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award, with an ID of SPE2DB22D2007|SPE2DB24FH6LG, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,427.26 firm fixed-price delivery order is for the supply of 4562584949 units of VYVANSE 70 MG CAPSULE 100S, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, held by...
This federal contract award, valued at $2,129.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of VYVANSE 40 MG CAPSULE 100S. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical...
This federal contract award, valued at $7,499.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract provides for the delivery of VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product, to support military...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,113.66, is for the delivery of VYVANSE 70 MG CAPSULE 100S to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order that runs through April 14, 2025. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award, identified as SPE2DB20D3505|SPE2DB25FU1Y8, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567604164 VYVANSE 60 MG CAPSULE 100S, a prescription medication, with a ceiling value of $1,337.70 and a performance period through March 18, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at...